Keywords: Parkinson's Disease, Parkinson's Disease, glymphatic dysfunction, DTI-ALPS
Motivation: Understanding the role of brain glymphatic dysfunction in Parkinson's disease (PD) is crucial for exploring potential therapeutic targets.
Goal(s): To evaluate the abnormality of ALPS-index and its association with clinical parameters in PD patients.
Approach: 71 PD patients and 102 healthy controls underwent MRI scans. The ALPS index was calculated using DTI-ALPS. PD patients were classified into early and advanced stages using k-means. Statistical analyses compared groups and correlations.
Results: 44 early PD and 27 advanced PD patients. Advanced PD showed significantly lower ALPS-index compared to HCs and early PD, with better diagnostic performance (AUC=0.71) and significant correlations with age and disease severity.
Impact: Alps-index changes intensify in advanced PD stages, indicating potential as a progression marker. This emphasizes the need for longitudinal studies to validate it as a tool for monitoring PD progression and assessing therapeutic interventions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords